Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2023-12-21 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
北京诺禾致源科技股份有限公司关于调整向特定对象发行股票募投项目拟投入募集资金金额的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Beijing Nuohua Zhiyuan Technology Co., Ltd. regarding the adjustment of the amount of funds to be invested from a specific share issuance fundraising project. It details the original fundraising, the actual net proceeds, and the adjustments to the investment amounts in various projects. It includes references to regulatory approvals, independent director opinions, supervisory board opinions, and sponsor institution verification. The document is a formal disclosure about changes in the use of raised capital, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive content about the adjustment itself. The document fits the category of Capital/Financing Update (CAP) as it relates to changes in fundraising and capital allocation from a specific share issuance.
2023-12-21 Chinese
中信证券股份有限公司关于北京诺禾致源科技股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from CITIC Securities regarding the use of temporarily idle raised funds by Beijing Nuohe Zhiyuan Technology Co., Ltd. for cash management. It includes specifics about the fundraising, investment projects, usage of funds, risk control measures, internal decision-making procedures, and the sponsor's verification opinion. The document references regulatory guidelines on the management and use of raised funds and includes formal approvals from the board, independent directors, and the supervisory board. It is not a financial report like an annual or interim report, nor is it a simple announcement or certification. It is a specialized audit or verification report related to the use of raised funds and compliance with regulatory requirements. Therefore, it fits best under the category of Audit Report / Information (AR).
2023-12-21 Chinese
北京诺禾致源科技股份有限公司第三届监事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Beijing Nuohe Zhiyuan Technology Co., Ltd. It details the meeting date, attendance, and the approval of several proposals related to the use and management of raised funds. The content focuses on internal governance decisions and compliance with regulatory guidelines regarding fundraising and fund usage. There are no financial statements, earnings data, or detailed financial analysis present. The document is an official announcement of board resolutions rather than a full report or financial filing. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or management bodies.
2023-12-21 Chinese
北京诺禾致源科技股份有限公司独立董事关于第三届董事会第十四次会议相关事项的独立意见
Capital/Financing Update Classification · 95% confidence The document is an independent opinion from independent directors regarding specific board meeting proposals related to the adjustment and use of funds raised from a private placement of shares. It references compliance with regulatory guidelines on the management and use of raised funds, and it discusses approval of proposals related to the use of raised funds and cash management. The document is not a full financial report, earnings release, or annual report, but rather a formal opinion on board meeting agenda items concerning capital use and fundraising compliance. It is not a simple announcement but a detailed independent director opinion on financing-related matters. Therefore, the document best fits the category of Capital/Financing Update (CAP). The document length is short but contains substantive content on capital use and fundraising matters, not just an announcement or certification, so it is not RPA or RNS.
2023-12-21 Chinese
立信会计师事务所（特殊普通合伙）关于北京诺禾致源科技股份有限公司以自筹资金预先投入募集资金投资项目及发行费用情况的鉴证报告
Regulatory Filings
2023-12-21 Chinese
中信证券股份有限公司关于北京诺禾致源科技股份有限公司使用募集资金置换已预先投入的自筹资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the use of raised funds by Beijing Novogene Technology Co., Ltd. to replace self-raised funds previously invested. It includes specifics about the fundraising, investment projects, board and supervisory approvals, independent director opinions, and an auditor's verification report. The content focuses on compliance with regulatory requirements for the use of raised funds and the replacement of self-raised funds, with no financial statements or earnings data presented. This type of document is a formal audit or verification report related to fundraising and fund usage, not a full annual or interim report, nor a simple announcement. Therefore, it fits best under the category of Audit Report / Information (AR).
2023-12-21 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.